Spyre Therapeutics Appoints Kate Tansey Chevlen as Chief Commercial Officer
Position
Chief Commercial Officer
Company
Spyre Therapeutics
WalthamBiotechnologyHealth CareTherapeuticsDescription
Spyre Therapeutics strengthens its leadership team with the appointment of Kate Tansey Chevlen as Chief Commercial Officer. Her extensive experience in global biopharma will support the company's development and commercialization efforts.
Quick answer
Spyre Therapeutics Appoints Kate Tansey Chevlen as Chief Commercial Officer (January 17, 2026). Spyre Therapeutics is based in Waltham, Massachusetts, United States.
- Who is the new Chief Commercial Officer at Spyre Therapeutics?
- Spyre Therapeutics named Kate Tansey Chevlen Chief Commercial Officer, announced January 17, 2026.
- What did Spyre Therapeutics announce on January 17, 2026?
- Spyre Therapeutics strengthens its leadership team with the appointment of Kate Tansey Chevlen as Chief Commercial Officer. Her extensive experience in global biopharma will support the company's development and commercialization efforts.
- What does Spyre Therapeutics do?
- Spyre Therapeutics is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (“IBD”) and rheumatic diseases.
- Where is Spyre Therapeutics based?
- Spyre Therapeutics is based in Waltham, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Emmecell (January 16, 2026), HaemaLogiX (January 15, 2026), Flashpoint Therapeutics (January 14, 2026) and Veristat (January 13, 2026) also announced leadership changes within 45 days of Spyre Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Emmecell Appoints Ramin Valian as Chief Executive Officer (January 16, 2026)
- HaemaLogiX Appoints Dr Chris Baldwin as Chief Executive Officer (January 15, 2026)
- Flashpoint Therapeutics Appoints Venkat R. Krishnamurthy as Chief Scientific Officer (January 14, 2026)
- Veristat Appoints Kim McLean Boericke as Chief Executive Officer (January 13, 2026)
- BioMarin Appoints Arpit Davé as Chief Digital and Information Officer (January 12, 2026)
- Ocular Therapeutix Appoints David W. Robinson as Global Chief Commercial Officer (January 21, 2026)
Who to call at Spyre Therapeutics, and when
A new leader at Spyre Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Spyre Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Spyre Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Spyre Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Spyre Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Spyre Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.